The objective of this study was to evaluate Gene Xpert MTB/RIF Assay and anid fast staining (AFB) for rapid detection of Mycobacterium tuberculosis in specimen of patients suspected of pulmonary tuberculosis (PTB) and extra pulmonary tuberculosis (EPTB).
INTRODUCTION
Tuberculosis (TB) is considered one of the most important infectious diseases through the course of human history which can affect nearly any organ in the body, but it mostly causes lung infections (Azadi et al. 2018) . Tuberculosis is a communicable disease resulting from infection with Mycobacterium tuberculosis whose principal reservoir is man and also, but infrequently, with other mycobacterium belonging to the Mycobacterium tuberculosis complex (Ayieko 2015) .
According to the Global TB Report 2017, tuberculosis mortality rate was 23 per 100,000 populations, which includes both HIV positive and HIV negative people. It causes ill-health in millions of people each year and in 2015 was one of the top 10 causes of death worldwide, ranking above HIV/AIDS as one of the leading causes of death from an infectious disease. As per Global TB report 2017, 6000 to 7000 people were dying per year from TB disease in Nepal. NTP registered 31764 all microscopy on 3 stained sputum specimens Sputum microscopy, the most widely available test for active TB (Matee et al. 2008) . Although smear microscopy for acid-fast bacilli (AFB) is rapid and inexpensive, it has poor sensitivity and a poor positive predictive value (PPV). In HIV infected patients with pulmonary TB, 24-61% have acid-fast negative sputum smear (Pinyopornpanish et al. 2015) . Mycobacterial culture is the gold standard and the most sensitive method for TB diagnosis; however, the use in clinical practice is limited due to a slow turnaround time (2 to 8 weeks), biosafety requirements, and high cost. Several studies have demonstrated that Xpert assay is highly sensitive and specifi c in diagnosis of both pulmonary and extrapulmonary TB (Pinyopornpanish et al. 2015) .
Thus, rapid identifi cation, which is essential for earlier treatment initiation, improved patient outcomes, and more effective public health interventions, relies on nucleic acid amplifi cation techniques. The GeneXpert MTB/RIF assay is a novel integrated diagnostic device that performs sample processing and heminested real-time PCR analysis in a single hands-free step for the diagnosis of tuberculosis and rapid detection of RIF resistance in clinical specimens (Zeka et al. 2011) . 
MATERIALS AND METHODS

RESULTS
A total of 400 specimens from TB suspected subjects were recruited in the study of which 283(70.75%) were male and 117(29.25%) were female with a male to female ratio of 2.42:1. Most of the subjects 98 (28.50%) were in the age 65 yrs and above (Table 1) . (Table 3) . (Table 4 ). 
